Business Wire

DXC Technology Unveils DXC Bionix™ to Provide Automated IT Services at Scale

Jaa

DXC Technology (NYSE: DXC), the world’s leading independent, end-to-end IT services company, today unveiled DXC Bionix™, a new digital-generation services delivery model that promises to provide a comprehensive approach to intelligent automation at the scale required by the world’s top companies.

DXC Bionix leverages analytics and AI, lean processes and leading automation capabilities to produce greater insight, speed and efficiency across the company’s global delivery ecosystem. DXC is leveraging DXC Bionix to respond to client demand for greater IT performance and the need to digitally transform traditional IT environments and processes.

For DXC’s global delivery operations, the performance gains from DXC Bionix have been impressive:

  • 50 percent to 80 percent reduction in time spent on operations;
  • 25 percent reduction in testing costs; 50 percent defect reduction; 60 percent reduction in testing time;
  • reduction in average applications deployment time from 180 minutes to 15 minutes;
  • a 65 percent reduction in business process transaction time with assisted Robotic Process Automation (RPA);
  • 71 percent of incidents auto-resolved or auto-diagnosed without human intervention; and
  • an 82 percent elimination of issues through rules-based filtering and alert correlation.

“Technology innovation and intelligent automation are rapidly changing the IT services business, and clients want to maximize performance and business outcomes from technology investments,” said Stephen Hilton, executive vice president, Global Delivery, DXC Technology. “By bringing smart industrial engineering into our delivery processes, we can work in a highly dynamic, repeatable and scalable way to deliver exceptional and transformative solutions to our clients.”

DXC Bionix uses real-time data collection and analysis to continuously measure and elevate performance. This helps the company, and ultimately its clients, make more informed decisions, eliminate waste, and produce more predictable results.

“We are also empowering our workforce by investing in our people, driving a cultural shift and elevating skillsets to ensure that DXC has the right digital-generation talent to optimally meet current and future clients’ needs,” Hilton noted. “For DXC, our partners and clients, DXC Bionix enables us to work smarter, faster and more efficiently—achieving new thresholds of quality and performance.”

Combining Analytics and AI, Lean Processes, and Intelligent Automation

DXC Bionix provides a complete, high-definition view of the IT services delivery operating environment to yield deeper learning and more useful information. The result is fewer business disruptions, reduced human error and operational risks and lower costs. And because it enables Straight Through Processing, DXC Bionix becomes a smart, fast, performance-driven and secure delivery engine that increases performance and agility across the enterprise.

There are three core elements of DXC Bionix:

  • Analytics and AI to gain new, real-time insights into the business and operations including data mining, machine learning and predictive intelligence to identify and proactively address opportunities for reducing costs and delivering innovation;
  • Lean processes to eliminate inefficiencies and continually improve solutions delivery, and optimize work flows and team performance for better quality, consistency and outcomes; and
  • Leading Automation capabilities, leveraging best-of-breed technologies from the DXC partner network combined with DXC innovation, to automate tasks, processes and workflows and to improve response time, accuracy and standardization.

“The next decade will see the mass adoption of artificial intelligence, machine learning and robotics within IT services which will reduce the unit cost of implementation,” Hilton added. “However, it will bring complexity.

“The competitive advantage of innovation will only be realized by companies that can simplify and manage this dynamic end-to-end at massive scale and as-a-service. DXC Bionix and its underlying platforms are how DXC will be at the forefront of this change, providing a competitive advantage for the company, our clients and partners.”

“A 70 percent reduction in backend incidents through predictive analytics is, from my stand point, amazing,” said Damian Bunyan, CIO, Uniper. “This is backed up by a near 20 percent automation of the remaining workload. This feeds directly into your business case (which is important) and provides welcome stability to my business units. I dream of such predictive maintenance in my generation fleet!”

Platform DXC and Agile Process Automation

Underpinning DXC Bionix is Platform DXC, the company’s digital-generation delivery platform that provides an important foundation for future services delivery — including applications, business process services, cloud, data analytics, security, and workplace and mobility solutions. Platform DXC allows DXC to quickly build and deliver partner-engineered, at-scale, repeatable offerings and solutions that help drive client digital transformations.

DXC’s recently announced Agile Process Automation (APA) is a new digital platform and a DXC Bionix enabled solution that combines cloud and robotic process automation (RPA) with embedded artificial intelligence (AI) to enhance a company’s business processes.

"Most end-user organizations don't have a line item in their budgets for digital transformation, so DXC Bionix is welcome news because it will help DXC identify where cash can be freed up from existing IT operations and reapplied to fund its clients' digital transformations," said Gard Little, vice president, Global Services Markets and Trends, IDC.

For more information on DXC Bionix, and to view a video featuring Steve Hilton, visit www.dxcbionix.com.

About DXC Technology

DXC Technology (NYSE: DXC) is the world’s leading independent, end-to-end IT services company, helping clients harness the power of innovation to thrive on change. Created by the merger of CSC and the Enterprise Services business of Hewlett Packard Enterprise, DXC Technology serves nearly 6,000 private and public sector clients across 70 countries. The company’s technology independence, global talent and extensive partner network combine to deliver powerful next-generation IT services and solutions. DXC Technology is recognized among the best corporate citizens globally. For more information, visit www.dxc.technology.

Contact information

DXC Technology
Richard Adamonis, Corporate Media Relations
+1-862-228-3481
radamonis@dxc.com
or
Donna Jenks, Corporate Media Relations
+1-630-306-9989
donna.jenks@dxc.com
or
Jonathan Ford, Investor Relations
+1-703-245-9700
jonathan.ford@dxc.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

CES Asia: Innovation at the Speed of 5G15.6.2018 17:59Tiedote

CES Asia® 2018 wrapped today with the rapid pace of global innovation front and center over the show’s three day duration. The next stage of technology advancements were showcased across vehicle tech, robotics, artificial intelligence (AI), virtual and augmented reality, digital health and more. The event, 24 percent larger than last year in terms of footprint, cemented itself as the place to fully experience how the pace of technology is accelerating globally. CES Asia, the premier event for tech innovation in the Asian marketplace, will return to Shanghai, China, June 11-13, 2019. “5G and AI are igniting growth across the entire tech ecosystem changing the way we interact with technology and the world around us,” said Gary Shapiro, president and CEO, Consumer Technology Association (CTA)™. “It’s incredible to see technology refining and reinventing itself at such a fast pace. Just six months ago we were at CES with life-altering tech all around us. This week, I saw that technology re

bluebird bio Presents New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin™ Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia at Annual Congress of the European Hematology Association15.6.2018 13:00Tiedote

bluebird bio, Inc. (Nasdaq: BLUE) announced that new data from the completed Phase 1/2 Northstar (HGB-204) study in adolescents and adults with transfusion-dependent β-thalassemia (TDT) and any genotype, and its ongoing, Phase 3 Northstar-2 (HGB-207) multicenter clinical study of LentiGlobin™ investigational gene therapy in patients with TDT and non-β0/β0 genotypes, will be presented in an oral session on June 16 at the 23rd Annual Congress of the European Hematology Association by Franco Locatelli, M.D., Ph.D., of the IRCCS Ospedale Pediatrico Bambino Gesù of Rome, Italy. “The maturing data from HGB-204 and HGB-207 suggest that one-time treatment with LentiGlobin may address the underlying genetic cause of TDT. With our refined manufacturing process, the majority of patients with TDT and non-β0/β0 genotypes are transfusion-free and producing total hemoglobin at normal or near-normal levels,” said David Davidson, M.D., chief medical officer, bluebird bio. “We are on track to submit a m

bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobin™ Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association15.6.2018 13:00Tiedote

bluebird bio, Inc. (Nasdaq: BLUE) today announced new interim data from the ongoing HGB-206 Phase 1 multicenter clinical study of LentiGlobin investigational gene therapy in patients with severe sickle cell disease (SCD) will be presented in an oral presentation on Saturday, June 16 at the 23rd Congress of the European Hematology Association (EHA) by Julie Kanter, M.D., Medical University of South Carolina, Charleston, South Carolina. “The consistent production of increased amounts of anti-sickling HbAT87Q in the Group C patients reflects the substantial positive impact of the changes introduced with the amended HGB-206 study protocol and refined manufacturing process. All four Group C patients with greater than or equal to three months follow-up are making over 30 percent anti-sickling HbAT87Q. The first patient treated, now with six months of follow-up, is producing over 60 percent anti-sickling HbAT87Q with a normal total hemoglobin level of 14.2 g/dL,” said David Davidson, M.D., ch

AGP Group Announces the Acquisition of Soliver NV in Belgium, Representing a Key Step towards Becoming the Premier Global Leader in Designing and Manufacturing High-Tech Automotive Glazing15.6.2018 12:00Tiedote

AGP, a high-tech specialty glass designer and manufacturer, has announced today the acquisition of Soliver NV, a European automotive glazing manufacturer with over 65 years of solid product and brand reputation. Soliver offers high-quality tempered and laminated glazing for high-end automobiles, as well as windshield solutions for trucks. AGP’s glazing heritage started in Berlin, with the Mannheim family´s first glass company. After 100 years and a clear vision to become a leader in specialty glass, AGP’s core eGlass technologies have responded to the rising demand in electrification, connectivity, shared mobility and autonomous driving, acting as an enabler of future mobility trends. The integration of Soliver into the AGP Group will strengthen the AGP eGlass value proposition and will be a game changer in a fast-evolving industry. “We are very excited to build upon Soliver’s great experience and track-record to take high-tech glazing to the next level, enabling our customer’s product

Rivoli Group announces completion of its new international corporate strategy15.6.2018 10:00Tiedote

Rivoli Group AG completes its comprehensive operational restructuring process and acts with a new presence in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180615005085/en/ Rivoli Group Announces Completion of Its New International Corporate Strategy (Photo: Business Wire) The Swiss based Rivoli Group AG has now completed the comprehensive restructuring process as part of the international realignment of its corporate strategy. After an intensive evaluation of the situation, the available resources and existing market potential, the Chairman of the Board of Directors Mr. Mourad Malloul, the management team and an international advisory committee coordinated the strategy together. "This is the beginning of a crucial new chapter for the Rivoli Group," the President and CEO of Rivoli Group AG said. The measure aims to strengthen the competitive advantages within the company group, to adjust their service offerings

PMI’s Latest Clinical Results: Findings Add to Extensive Evidence Package on Risk Reduction15.6.2018 10:00Tiedote

Philip Morris International (PMI) (NYSE:PM) announces today the positive results from a new clinical study on IQOS, the company’s most advanced smoke-free product. The Exposure Response Study (ERS) measured the biological response of people who switch to IQOS for six months compared with continued smoking. The study met its primary objective, demonstrating that after six months, eight measures of biological response (the primary clinical risk endpoints) improved in those who switched to IQOS. PMI’s Scientific Assessment Program has rigorously tested IQOS over more than 7 years and supports that switching to our most advanced smoke-free product is likely to present less risk of harm than continuing to use cigarettes. Numerous aerosol chemistry and physics measurements demonstrate that IQOS aerosol contains an average of 90-95% lower levels of harmful constituents. Our results support that these reduced emissions translate to reduced toxicity in the laboratory and to reduced exposure in

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme